Skip to main content
. 2021 Oct 12;10(20):4667. doi: 10.3390/jcm10204667

Figure 4.

Figure 4

Blockage of co-stimulatory pathways influences corneal-allograft survival. (A) CLTA-4 Ig promotes allograft survival. (B) Anti-CD154 antibody increases the allograft survival rate. (C) CCR7-CCL19 blockade improves the allograft survival rate. CI, confidence intervals; EV, event; Trt, treatment; Ctrl, control.